Cancer Cachexia Pipeline Insights Report, 2024 Featuring Emerging Drugs Macimorelin (AEterna Zentaris) and PF-06946860 (Pfizer)
22 mai 2024 10h11 HE
|
Research and Markets
Dublin, May 22, 2024 (GLOBE NEWSWIRE) -- The "Cancer Cachexia - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...